Renaissance Technologies - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 157 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,040
-20.2%
256,152
-1.7%
0.01%0.0%
Q2 2023$5,064
-14.5%
260,473
+24.7%
0.01%
-12.5%
Q1 2023$5,925
-24.0%
208,850
-21.7%
0.01%
-27.3%
Q4 2022$7,794
-99.9%
266,650
-2.8%
0.01%
+10.0%
Q3 2022$7,246,000
-35.5%
274,279
+8.4%
0.01%
-23.1%
Q2 2022$11,240,000
+6.3%
252,979
+18.4%
0.01%
+8.3%
Q1 2022$10,570,000
-0.1%
213,579
+2.8%
0.01%
-7.7%
Q4 2021$10,580,000
-6.2%
207,779
+2.7%
0.01%
-13.3%
Q3 2021$11,283,000
+33.9%
202,279
+2.7%
0.02%
+36.4%
Q2 2021$8,426,000
-1.4%
196,879
-3.8%
0.01%0.0%
Q1 2021$8,543,000
-19.3%
204,679
-9.9%
0.01%0.0%
Q4 2020$10,580,000
-12.9%
227,179
-20.6%
0.01%
-8.3%
Q3 2020$12,149,000
-27.6%
286,000
-18.2%
0.01%
-14.3%
Q2 2020$16,769,000
+26.3%
349,500
+21.1%
0.01%
+7.7%
Q1 2020$13,276,000
+41.0%
288,600
+84.2%
0.01%
+85.7%
Q4 2019$9,415,000
+358.6%
156,700
+331.7%
0.01%
+250.0%
Q3 2019$2,053,000
+8.5%
36,300
+55.1%
0.00%
-50.0%
Q2 2015$1,892,000
-24.6%
23,400
-60.9%
0.00%
-20.0%
Q1 2015$2,509,00059,9000.01%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Tri Locum Partners LP 94,922$4,063,0001.33%
Smith, Graham & Co., Investment Advisors, LP 277,572$11,880,0001.05%
Krensavage Asset Management, LLC 70,804$3,030,0001.03%
BRANDES INVESTMENT PARTNERS, LP 716,873$30,682,0000.68%
GLOBEFLEX CAPITAL L P 42,357$1,813,0000.33%
Zebra Capital Management LLC 6,472$277,0000.32%
Capital Impact Advisors, LLC 19,276$825,0000.27%
Hein Park Capital Management LP 31,977$1,369,0000.26%
CHARTWELL INVESTMENT PARTNERS, LLC 195,340$8,361,0000.25%
Stanley-Laman Group, Ltd. 24,000$1,027,0000.15%
View complete list of EAGLE PHARMACEUTICALS INC shareholders